Mother and child (MDMG) Stock Nɛnɛya
Prévision IA: MDMG
AI bɛ sɔrɔli kɔrɔtɔli sɔrɔ sisan kɔnɔ, kɔnɔ sɔrɔli ni kɔnɔ sɔrɔli. Bɛnɛya bɛ sɔrɔ kɔnɔ sɔrɔli kɔnɔ. O bɛɛ bɛ sɔrɔ ni statistiki, a tɛ jɛya kɔrɔtɔli.
Prix sur les 6 derniers mois
Premium affiche les objectifs de prix de l'IA à 1 jour, 1 semaine et 1 mois pour cette action et toutes les autres.
Débloquer Premium🔒 Nɛnɛya kɔrɔtɔli sɔrɔli
Nɛnɛya kɔrɔtɔli sɔrɔli — nɛnɛya bɛɛ ni kɔnɔ sɔrɔli — bɛ Premium kɔnɔ.
Débloquer PremiumƝɛnɛ kɔnɔ bɛnɛ
Mater and Ditya is one of the leaders of the Russian private healthcare market. Founded in 2006 by obstetrician-gynecologist Mark Kurtser, the company now holds a leading position in Russia in the field of women’s and children’s health. The company’s assets include 11 high-tech hospitals, 44 clinics, and one medical university. The medical facilities specialize in a broad range of healthcare services, providing care in reproductive medicine, women’s health, and pediatrics, as well as in the treatment of socially significant diseases, including oncology and cardiology. In 2022, the company ranked second in Forbes’ “Top 20 Medical Companies – 2022” ranking, with revenue of RUB 25 billion.
